Literature DB >> 10765142

Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection.

J Peterson1, G Green, K Iida, B Caldwell, P Kerrison, S Bernich, K Aoyagi, S R Lee.   

Abstract

BACKGROUND AND OBJECTIVES: Despite improvements in assays for anti-HCV, there remains a significant delay before the appearance of antibodies following infection, during which, circulating viral RNA is present. We have evaluated a prototype assay for the serological detection of hepatitis C virus (HCV) core antigen with specimens derived from the early phase of HCV infection.
MATERIALS AND METHODS: Serial specimens from 24 individuals undergoing HCV seroconversion were tested for the presence of anti-HCV, HCV RNA and HCV core antigen.
RESULTS: HCV antigen was detected at the same time as HCV RNA in 83% (20/24) cases. The mean time to the first detection of HCV antigen was approximately 1 day later than HCV RNA. Overall, 87% of HCV-RNA-positive specimens contained detectable HCV core antigen.
CONCLUSION: These results indicate that HCV core antigen can be identified by routine serological ELISA in specimens from the early antibody-negative phase of HCV infection. A test for HCV core antigen may be a useful test for identifying window phase blood donations from antibody negative donors infected with HCV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10765142     DOI: 10.1159/000031155

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  16 in total

Review 1.  Current testing strategies for hepatitis C virus infection in blood donors and the way forward.

Authors:  Neelam Marwaha; Suchet Sachdev
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup.

Authors:  Catherine Gaudy; Catherine Thevenas; Jean Tichet; Nicole Mariotte; Alain Goudeau; Frédéric Dubois
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results.

Authors:  Recep Kesli; Hakki Polat; Yuksel Terzi; Muhammet Guzel Kurtoglu; Yavuz Uyar
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.

Authors:  Syria Laperche; Nadine Le Marrec; Annie Girault; Françoise Bouchardeau; Annabelle Servant-Delmas; Michèle Maniez-Montreuil; Pierre Gallian; Thierry Levayer; Pascal Morel; Nicole Simon
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.

Authors:  G Icardi; F Ansaldi; B M Bruzzone; P Durando; S Lee; C de Luigi; P Crovari
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.

Authors:  P Maillard; K Krawczynski; J Nitkiewicz; C Bronnert; M Sidorkiewicz; P Gounon; J Dubuisson; G Faure; R Crainic; A Budkowska
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients.

Authors:  Fabrizio Fabrizi; Giovanna Lunghi; Filippo Aucella; Stefano Mangano; Francesco Barbisoni; Sergio Bisegna; Domenico Vigilante; Aurelio Limido; Paul Martin
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 8.  Hepatitis C-Z: recent advances.

Authors:  D Kelly; S Skidmore
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

9.  Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.

Authors:  He-Qiu Zhang; Shao-Bo Li; Guo-Hua Wang; Kun Chen; Xiao-Guo Song; Xiao-Yan Feng
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

10.  Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.

Authors:  Kara L Cummings; Hugo R Rosen; Young S Hahn
Journal:  Clin Immunol       Date:  2009-05-26       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.